Literature DB >> 7772494

Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins.

C Mohr1, C Sunderkötter, A Hildebrand, K Biel, A Rütter, G H Rütter, T A Luger, G Kolde.   

Abstract

We report a 55-year-old man with severe inflammatory epidermolysis bullosa acquisita. The skin lesions did not respond to various immunosuppressive treatments. The combined administration of prednisone, azathioprine, dapsone and colchicine resulted only in a transient and incomplete resolution of the lesions. The bullae and increased skin fragility were successfully controlled by the addition of high-dose intravenous immunoglobulin therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7772494     DOI: 10.1111/j.1365-2133.1995.tb00735.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.

Authors:  S Jolles
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

2.  [Mucosal epidermolysis bullosa acquisita complicated by laryngeal stenosis].

Authors:  S Ritzmann; W Angerstein; N J Neumann; M Megahed
Journal:  Hautarzt       Date:  2004-10       Impact factor: 0.751

Review 3.  Epidermolysis bullosa acquisita.

Authors:  Rishu Gupta; David T Woodley; Mei Chen
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

Review 4.  Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen.

Authors:  Mei Chen; Gene H Kim; Lori Prakash; David T Woodley
Journal:  Autoimmunity       Date:  2011-09-28       Impact factor: 2.815

Review 5.  High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.

Authors:  Norito Ishii; Takashi Hashimoto; Detlef Zillikens; Ralf J Ludwig
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

6.  Epidermolysis bullosa acquisita with moderately severe Dysphagia due to esophageal strictures.

Authors:  Jenny Tu; Prasad W Kumarasinghe
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

7.  Therapy of autoimmune bullous diseases.

Authors:  Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

Review 8.  Epidermolysis Bullosa Acquisita: The 2019 Update.

Authors:  Hiroshi Koga; Catherine Prost-Squarcioni; Hiroaki Iwata; Marcel F Jonkman; Ralf J Ludwig; Katja Bieber
Journal:  Front Med (Lausanne)       Date:  2019-01-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.